eFluor 450 Enables Superior Detection of Intracellular Staphylococcus aureus in High‐Autofluorescence Triple‐Negative Breast Cancer Cells
Cytometry Part A · 2026-02 · 109 (2) · 135-146
DOI: 10.1002/cyto.a.70019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part A, online erschienen am 26.02.2026. Verfasst von Sima Kianpour Rad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Central Adelaide Local Health Network, Ad…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Staphylococcus aureus, Flow Cytometry, Fluorescent Dyes. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Accurate discrimination of extracellular from intracellular bacteria is critical for assessing microbial invasiveness in host cells. Flow cytometry offers high‐throughput, quantitative analysis but can be confounded by high autofluorescence in certain tumor‐derived cell types. This study compared the performance of two fluorescent dyes, carboxyfluorescein succinimidyl ester (CFSE), a widely used cell‐permeant dye, and eFluor 450, a fixable amine‐reactive dye, for labeling Staphylococcus aureus during intracellular infection of triple‐negative breast cancer cell lines. Both dyes produced multiplicity‐of‐infection–dependent increases in fluorescence; however, eFluor 450 consistently achieved superior population separation and higher estimated fluorochrome abundance following spectral unmixing, even in highly autofluorescent backgrounds. These differences reflect more favorable spectral separation from cellular autofluorescence rather than generic signal enhancement. Operationally, eFluor 450 required shorter labeling time and lower reagent volume than CFSE without compromising bacterial viability. The advantages of eFluor 450 were most pronounced at low bacterial loads and in applications requiring precise population discrimination. To our knowledge, this is the first demonstration of eFluor 450 for intracellular bacterial detection by spectral flow cytometry in cancer models. Together, these findings establish eFluor 450 as an efficient alternative to conventional dyes and highlight the importance of fluorochrome spectral properties for unmixing‐based host–pathogen analyses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.
- Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
- Medical Oncology, The Queen Elizabeth Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.
- Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
- Discipline of Surgery, The University of Adelaide, Adelaide, South Australia, Australia.
ORCID-Profile: Runhao Li, Wendy V Ingman
Zitieren
APA
Rad, S. K., Li, R., Yeo, K. K. L., Tomita, Y., Price, T. J., Ingman, W. V., Townsend, A. R., & Smith, E. (2026). eFluor 450 Enables Superior Detection of Intracellular Staphylococcus aureus in High‐Autofluorescence Triple‐Negative Breast Cancer Cells. Cytometry Part A, 109(2), 135-146. https://doi.org/10.1002/cyto.a.70019
Vancouver
Rad SK, Li R, Yeo KKL, Tomita Y, Price TJ, Ingman WV, et al. eFluor 450 Enables Superior Detection of Intracellular Staphylococcus aureus in High‐Autofluorescence Triple‐Negative Breast Cancer Cells. Cytometry Part A. 2026;109(2):135-146. doi:10.1002/cyto.a.70019
BibTeX
@article{Rad2026,
author = {Rad, Sima Kianpour and Li, Runhao and Yeo, Kenny K L and Tomita, Yoko and Price, Timothy J and Ingman, Wendy V and Townsend, Amanda R and Smith, Eric},
title = {eFluor 450 Enables Superior Detection of Intracellular Staphylococcus aureus in High‐Autofluorescence Triple‐Negative Breast Cancer Cells},
journal = {Cytometry Part A},
year = {2026},
volume = {109},
number = {2},
pages = {135--146},
doi = {10.1002/cyto.a.70019}
}
EUVIMED